Fieldpoint Private Securities’s West Pharmaceutical WST Stock Holding History

Fieldpoint Private Securities’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$9K	Sell	30 -171	-85%	-$55.6K	﹤0.01%	763
2022 Q1	$83K	Sell	201 -10	-5%	-$3.92K	0.02%	466
2021 Q4	$99K	Buy	211 +9	+4%	+$3.87K	0.02%	447
2021 Q3	$86K	Sell	202 -10	-5%	-$4.22K	0.02%	447
2021 Q2	$90K	Sell	212 -37	-15%	-$12.2K	0.02%	440
2021 Q1	$70K	Buy	249 +60	+32%	+$17.2K	0.02%	479
2020 Q4	$54K	Buy	+189	New	+$53K	0.01%	470
2020 Q1	–	Sell	-151	Closed	-$23K	–	574
2019 Q4	$23K	Buy	151 +25	+20%	+$3.64K	0.01%	534
2019 Q3	$18K	Hold	126	–	–	0.01%	525
2019 Q2	$16K	Buy	+126	New	+$14.9K	0.01%	561

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fieldpoint Private Securities's WST Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its West Pharmaceutical (WST) stake by 85% in Q2 2022, selling an estimated $55.6K and leaving 30 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #763.

Fieldpoint Private Securities first reported a position in WST in Q2 2019 and has held it in 10 quarters since. The position peaked at $99K in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

Fieldpoint Private Securities held 30 shares of West Pharmaceutical worth $9K as of Q2 2022.
Fieldpoint Private Securities sold 171 West Pharmaceutical shares in Q2 2022, an estimated $55.6K.
West Pharmaceutical made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #763 holding.
Fieldpoint Private Securities first reported a position in West Pharmaceutical in Q2 2019 and has held it in 10 quarters since.
Fieldpoint Private Securities's West Pharmaceutical position peaked at $99K in Q4 2021.
655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.